Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 2Recruiting 2Completed 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1Cancer Cachexia 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Capsules × Clear all
NCT03774680 2019-10-10

Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer

Al-Azhar University

Phase 1 Unknown
30 enrolled
Gastrointestinal

Colonic Neoplasms

NCT03631459 2018-08-21

A Multicenter Real World Study of Kanglaite for Cancer Cachexia

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Unknown
100,000 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡